Discovery of compound candidates for the treatment of allergic diseases: integration of DFT analyses, molecular docking, molecular dynamics simulations, and ADMET profiling [0.03%]
基于DFT分析、分子对接、分子动力学模拟及ADMET性质评价的过敏疾病治疗化合物的发现
Velid Unsal,Erkan Oner,Reşit Yıldız et al.
Velid Unsal et al.
Correction: Integrated network toxicology, machine learning and molecular docking reveal the mechanism of benzopyrene-induced periodontitis [0.03%]
纠正：整合网络毒理学、机器学习和分子对接揭示苯并[a]芘诱导的牙周炎的作用机制
Wenjie Wen,Rui Li,Pengpeng Zhuo et al.
Wenjie Wen et al.
Published Erratum
BMC pharmacology & toxicology. 2026 Mar 3;27(1):45. DOI:10.1186/s40360-026-01100-8 2026
Development and validation of a population pharmacokinetic model for lacosamide in adult patients with epilepsy to inform precision dosing [0.03%]
用于指导癫痫患者精准治疗的拉考沙胺成人人群药代动力学模型的开发与验证
Lingyan Yu,Fengqian Mao,Shunan Chen et al.
Lingyan Yu et al.
The anticancer properties of the nanocomposite of low-nanoscale Ag nanoparticles obtained in SiO2-grafted polyacrylamide carrier [0.03%]
低纳米级Ag纳米粒子的硅烷化聚丙烯酰胺载体制备的纳米复合材料的抗肿瘤性能
Olga V Akopova,Tatyana Zheltonozhskaya,Svitlana Zahorodnia et al.
Olga V Akopova et al.
Crossing ocular barriers with quercetin-SPIONs: modulation of Bax/Bcl-2 balance in normal rat eyes [0.03%]
槲皮素-SPIONS跨越眼部屏障：调节正常大鼠眼睛中Bax/Bcl-2平衡
Mahtab Hajiaghajanian,Nazanin Movahedi,Dorsa Pouriaii et al.
Mahtab Hajiaghajanian et al.
Effects of CYP1A2 genetic polymorphisms on the pharmacokinetics of pentoxifylline and its active metabolites [0.03%]
CYP1A2基因多态性对氨茶碱药代动力学及其活性代谢产物的影响
Lingfang Guo,Xue Sun,Bo Qiu et al.
Lingfang Guo et al.
Clinical pharmacist-led prevention of intravenous drug incompatibilities in an adult ICU: a prospective observational study [0.03%]
成人ICU临床药剂师领导的预防静脉用药不相容性的前瞻性观察研究
Tülay Kayra,Leyla Ferliçolak,İlker Ateş et al.
Tülay Kayra et al.
Penetration and disruption of Salmonella typhimurium biofilm using synthesized citric acid doped zein nanocomposites [0.03%]
采用合成柠檬酸掺杂的玉米醇溶蛋白纳米复合材料渗透及破坏大肠杆菌生物被膜性能的研究
Venkteshwar Yadav,Dharm Pal,Anil Kumar Poonia
Venkteshwar Yadav
Investigating the mechanisms by which bisphenol A affects osteoarthritis through a novel network toxicology framework and experimental validation [0.03%]
通过一种新的网络毒理学框架研究双酚A影响骨关节炎的机制并进行实验验证
Qiwang He,Shanlang Li,Yining Chen et al.
Qiwang He et al.
Adverse events associated with tirzepatide: a focus on subgroup-specific differences [0.03%]
针对特定亚组差异的 tirzepatide相关不良事件
Zhongming Yu,Yiming Qi,Qian Gan et al.
Zhongming Yu et al.